Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
A brief guide to blue chip alternatives beyond BTC and ETH, highlighting characteristics that define blue chip status and potential rewards.
20,411 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Macerich faces a retail landscape that’s evolved in 2025. This deep dive breaks down the factors shaping macerich (ma...
ServiceNow has faced a brutal market sell-off in 2026. This guide breaks down whether the decline creates a compellin...
Kratos Defense stock just moved lower after a compelling earnings beat, leaving investors wondering what comes next. ...
Lilly shares moved lower after Novo Nordisk announced price cuts on leading obesity drugs, signaling a tougher compet...
As market conditions shift in 2026, five very safe high-yield dividend stocks stand out for lifelong ownership, backe...
A high-profile investor sends a pointed message about Whirlpool’s strategy. This article explains what the billionair...
RxSight's Q4 2025 earnings report could set the tone for its 2026 trajectory. This guide breaks down the key numbers,...
Freddie Mac reports mortgage rates fall below 6% this week for the first time since 2022, signaling relief for buyers...
As GoodRx navigates evolving discount dynamics and a changing membership model, the 2025 earnings picture will hinge ...
As XRP tests new volatility, investors debate shocking ripple price predictions that span from modest gains to outsiz...
As TTEC heads into 2025 earnings season, investors want a clear view of what could drive the numbers. This guide brea...